Online Makale
Online Hizmetlere Toplu BakışHaydarpasa Numune Egitim ve Arastirma Hastanesi Tip Dergisi
Haydarpasa Numune Med J. 2023; 63(1): 89-93 | DOI: 10.14744/hnhj.2022.99810 | |||
Is There a Relationship Between Omalizumab Treatment and the Development of Thromboembolic Events in Asthmatics?Şeyma BaşlılarDepartment of Pulmonology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, TürkiyeINTRODUCTION: Omalizumab is indicated for the treatment of uncontrolled moderate and severe allergic asthma. The long-term real-life studies showed that it may result in an increase in thromboembolic events (TEs). This single-center study was planned to evaluate whether the use of omalizumab was related to the development of thromboembolism and change in peripheral blood thrombocyte counts. Şeyma Başlılar. Is There a Relationship Between Omalizumab Treatment and the Development of Thromboembolic Events in Asthmatics?. Haydarpasa Numune Med J. 2023; 63(1): 89-93 Sorumlu Yazar: Şeyma Başlılar, Türkiye |
|